{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T20:22:11Z","timestamp":1770236531927,"version":"3.49.0"},"reference-count":31,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacoepidemiology and Drug"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>The objective of this study was to compare the prescribing information for elderly patients on drug labels in Japan, the United States (U.S.), and Europe to suggest improvements in Japanese package inserts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We surveyed drug labeling regulations in the three regions and selected 39 new drugs approved in Japan between 2012 and 2023 for diseases common in the elderly and approved in the U.S. and Europe. We examined the prescribing information for elderly patients such as dose adjustment instructions and comparison of safety profiles by age.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The results revealed that 7.7% of Japanese package inserts provided dosage adjustment instruction for elderly patients, compared with 46.2% and 79.5% of U.S. and European drug labels, respectively. Regarding safety profile comparisons between age groups, 30.8% of Japanese package inserts included this information compared with 94.9% and 23.1% of U.S. and European drug labels, respectively. No Japanese package inserts listed the number of elderly patients included in clinical trials; whereas this information appeared on 89.7% of U.S. labels and 7.7% of European summaries of product characteristics.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Japanese package inserts provide less prescribing information for elderly patients than U.S. and European drug labels. To promote appropriate drug use among elderly patients in Japan, package inserts should be improved by incorporating sufficient information, such as clear dosage adjustment instructions and differences in safety profiles by age groups. These enhancements would align Japanese package inserts with international quality, providing healthcare professionals with more comprehensive drug prescribing information for treating elderly patients.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pds.70195","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T06:04:23Z","timestamp":1755065063000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparison of Prescribing Information for Elderly Patients on Drug Labels in Japan, the United States, and Europe"],"prefix":"10.1002","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0927-7614","authenticated-orcid":false,"given":"Makoto","family":"Onohara","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine (Pharmaceutical Medicine), graduate School of Pharmaceutical Sciences Kitasato University  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoru","family":"Narukawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine (Pharmaceutical Medicine), graduate School of Pharmaceutical Sciences Kitasato University  Tokyo Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,8,12]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"A Japanese Package Insert With Quetiapine Fumarate Issued in October 2024 by Astellas [in Japanese] accessed December 31 2024 https:\/\/pins.japic.or.jp\/pdf\/newPINS\/00058102.pdf."},{"key":"e_1_2_11_3_1","first-page":"163","article-title":"Research on the Current Status of New Drug Development in and Information Provision for Elderly Patients","volume":"7","author":"Kanda Y.","year":"2017","journal-title":"Regulatory Science of Medical Products"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.b24-00437"},{"key":"e_1_2_11_5_1","unstructured":"Articles 52 of the Pharmaceutical Affairs Act Order of the Ministry of Health Labour and Welfare No. 145 of 1960 [in Japanese] accessed December 19 2024 https:\/\/laws.e\u2010gov.go.jp\/law\/335AC0000000145."},{"key":"e_1_2_11_6_1","unstructured":"Code of Federal Regulations Title 21 Section\u00a0201.100: Prescription Drugs for Human Use accessed December 19 2024 https:\/\/www.ecfr.gov\/current\/title\u201021\/chapter\u2010I\/subchapter\u2010C\/part\u2010201\/subpart\u2010D\/section\u2010201.100."},{"key":"#cr-split#-e_1_2_11_7_1.1","unstructured":"Directive 2001\/83\/EC of the European Parliament and of the Council of 6 November 2001 on the Community Code Relating to Medicinal Products for Human Use Article 11"},{"key":"#cr-split#-e_1_2_11_7_1.2","unstructured":"The Summary of the Product Characteristics Shall Contain the Following Information accessed December 19 2024 https:\/\/eur\u2010lex.europa.eu\/legal\u2010content\/EN\/TXT\/?uri=CELEX%3A32001L0083&qid=1734755807306."},{"key":"e_1_2_11_8_1","first-page":"635","article-title":"International Comparison of Contraceptive Information in the Package Insert","volume":"48","author":"Yonemura M.","year":"2021","journal-title":"Gan To Kagaku Ryoho"},{"key":"e_1_2_11_9_1","unstructured":"World Population Prospects 2022: Summary of Results by United Nations Department of Economic and Social Affairs Population Division UN DESA\/POP\/2021\/TR\/NO. 3 accessed December 31 2024 https:\/\/www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/wpp2022_summary_of_results.pdf."},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53273.x"},{"key":"e_1_2_11_11_1","unstructured":"US Food and Drug Administration WORKSHOP: Roadmap to 2030 for New Drug Evaluation in Older Adults accessed December 18 2024 https:\/\/www.fda.gov\/drugs\/news\u2010events\u2010human\u2010drugs\/roadmap\u20102030\u2010new\u2010drug\u2010evaluation\u2010older\u2010adults\u201003232021\u201003232021."},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2452"},{"key":"e_1_2_11_13_1","unstructured":"Inclusion of Older Adults in Cancer Clinical Trials Guidance for Industry accessed December 27 2024 https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/inclusion\u2010older\u2010adults\u2010cancer\u2010clinical\u2010trials."},{"key":"e_1_2_11_14_1","unstructured":"EMA Geriatric Medicines Strategy accessed December 27 2024 https:\/\/www.ema.europa.eu\/en\/documents\/other\/geriatric\u2010medicines\u2010strategy_en.pdf."},{"key":"e_1_2_11_15_1","unstructured":"Reflection Paper on the Pharmaceutical Development of Medicines for Use in the Older Population accessed December 27 2024 https:\/\/www.ema.europa.eu\/en\/documents\/scientific\u2010guideline\/reflection\u2010paper\u2010pharmaceutical\u2010development\u2010medicines\u2010use\u2010older\u2010population\u2010first\u2010version_en.pdf."},{"key":"e_1_2_11_16_1","unstructured":"I.Innami The Ministry of Health Labour and Welfare Guidance of Appropriate Medication for Elderly Patients: General 2018 [in Japanese] https:\/\/www.mhlw.go.jp\/content\/11121000\/kourei\u2010tekisei_web.pdf."},{"key":"e_1_2_11_17_1","unstructured":"I.Innami The Ministry of Health Labour and Welfare Guidance of Appropriate Medication for Elderly Patients: Particular (by Recuperation Environment) 2019 [in Japanese] https:\/\/www.mhlw.go.jp\/content\/11120000\/000568037.pdf."},{"key":"e_1_2_11_18_1","unstructured":"Pharmaceutical Safety and Environmental Health Bureau Ministry of Health Labour and Welfare The Instructions for Package Inserts of Prescription Drugs 2017 https:\/\/www.phrma\u2010jp.org\/wordpress\/wp\u2010content\/uploads\/2019\/05\/PSEHB\u2010Notification\u2010No.0608\u20101_E_1.1.pdf."},{"key":"e_1_2_11_19_1","unstructured":"Pharmaceutical Safety and Environmental Health Bureau Ministry of Health Labour and Welfare Q&A Associating the Instructions for Package Inserts of Prescription Drugs. February 17 2023 [in Japanese] https:\/\/www.mhlw.go.jp\/content\/11120000\/001060028.pdf."},{"key":"e_1_2_11_20_1","unstructured":"Code of Federal Regulations Title 21 Section\u00a0201.56 accessed December 27 2024 https:\/\/www.ecfr.gov\/current\/title\u201021\/chapter\u2010I\/subchapter\u2010C\/part\u2010201\/subpart\u2010B\/section\u2010201.56."},{"key":"e_1_2_11_21_1","unstructured":"Code of Federal Regulations Title 21 Section\u00a0201.57 accessed December 27 2024 https:\/\/www.ecfr.gov\/current\/title\u201021\/chapter\u2010I\/subchapter\u2010C\/part\u2010201\/subpart\u2010B\/section\u2010201.57."},{"key":"e_1_2_11_22_1","unstructured":"U.S. Food and Drug Administration Guidance Document: Content and Format for Geriatric Labeling Guidance for Industry 2001 https:\/\/www.fda.gov\/media\/72141\/download."},{"key":"e_1_2_11_23_1","unstructured":"U.S. Food and Drug Administration Guidance Document: Geriatric Information in Human Prescription Drug and Biological Product Labeling Guidance for Industry. Draft Guidance for Industry 2020 https:\/\/www.fda.gov\/media\/142162\/download."},{"key":"e_1_2_11_24_1","unstructured":"A Guideline on Summary of Product Characteristics 2009 https:\/\/health.ec.europa.eu\/document\/download\/6a043dea\u20107d0f\u20104252\u2010947b\u2010cef58f53d37e_en."},{"key":"e_1_2_11_25_1","unstructured":"Presentation\u2010Section\u00a04.2: Posology and Method of Administration accessed December 27 2024 https:\/\/www.ema.europa.eu\/en\/documents\/presentation\/presentation\u2010section\u201042\u2010posology\u2010method\u2010administration_en.pdf."},{"key":"e_1_2_11_26_1","unstructured":"M.Akishita The Japan Geriatrics Society Guidelines for Medical Treatment and Its Safety in the Elderly 2015 [in Japanese] https:\/\/www.jpn\u2010geriat\u2010soc.or.jp\/info\/topics\/pdf\/20170808_01.pdf."},{"key":"e_1_2_11_27_1","unstructured":"The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. E7: Studies in Support of Special Populations: Geriatrics 1993 https:\/\/database.ich.org\/sites\/default\/files\/E7_Guideline.pdf."},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.18953"},{"key":"e_1_2_11_29_1","unstructured":"Japanese Package Insert With Tirzepatide accessed June 6 2025 [in Japanese] https:\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/530471_2499422G1024_1_07."},{"key":"e_1_2_11_30_1","unstructured":"U.S. Label With Tirzepatide accessed June 6 2025 https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2025\/215866s031lbl.pdf."},{"key":"e_1_2_11_31_1","unstructured":"European SmPC With Tirzepatide. Annex I Summary of Product Characteristics accessed June 6 2025 https:\/\/www.ema.europa.eu\/en\/documents\/product\u2010information\/mounjaro\u2010epar\u2010product\u2010information_en.pdf."}],"container-title":["Pharmacoepidemiology and Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pds.70195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T04:42:10Z","timestamp":1758256930000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pds.70195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1002\/pds.70195"],"URL":"https:\/\/doi.org\/10.1002\/pds.70195","archive":["Portico"],"relation":{},"ISSN":["1053-8569","1099-1557"],"issn-type":[{"value":"1053-8569","type":"print"},{"value":"1099-1557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"2025-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70195"}}